Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of Mineralys Therapeutics Inc (NASDAQ: MLYS) closed at $8.76 in the last session, down -5.30% from day before closing price of $9.25. In other words, the price has decreased by -$5.30 from its previous closing price. On the day, 1.0 million shares were traded.
Ratios:
We take a closer look at MLYS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 14.02 and its Current Ratio is at 14.02. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on July 10, 2024, initiated with a Buy rating and assigned the stock a target price of $30.
On April 02, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $30.
On March 07, 2023, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $27.Wells Fargo initiated its Overweight rating on March 07, 2023, with a $27 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 13 ’25 when Levy Adam Scott sold 10,757 shares for $9.10 per share. The transaction valued at 97,864 led to the insider holds 226,097 shares of the business.
Congleton Jon sold 18,333 shares of MLYS for $166,082 on Jan 13 ’25. The Chief Executive Officer now owns 877,608 shares after completing the transaction at $9.06 per share. On Jan 13 ’25, another insider, Congleton Jon, who serves as the Officer of the company, bought 18,333 shares for $9.06 each.
Stock Price History:
Over the past 52 weeks, MLYS has reached a high of $16.91, while it has fallen to a 52-week low of $8.58. The 50-Day Moving Average of the stock is -18.79%, while the 200-Day Moving Average is calculated to be -28.07%.
Shares Statistics:
A total of 49.82M shares are outstanding, with a floating share count of 24.55M. Insiders hold about 50.67% of the company’s shares, while institutions hold 55.68% stake in the company.
